64th ASH Annual Meeting and Exposition: Data Worth Stopping For: New 5-year Follow-Up Data for an Oral-Based CLL Regimen with a Fixed Treatment Duration

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant.

denotes that this is a recommended PHD Trainee Session.

denotes that this is a ticketed session.

Data Worth Stopping For: New 5-year Follow-Up Data for an Oral-Based CLL Regimen with a Fixed Treatment Duration

Sponsor: AbbVie

Product Theaters

Hall J - Theater 1 (Ernest N. Morial Convention Center)

Speaker:

Ahmed Kotb, MD, AbbVie

Disclosures:

No relevant conflicts of interest to declare.

This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Product Theaters